HOME >> MEDICINE >> NEWS
Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs

Two new review studies evaluating the safety of the pain-relieving medications selective cyclooxygenase 2 (COX-2) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs) find increased cardiovascular and kidney risks. The studies and an accompanying editorial were posted online today by JAMA because of the public health implications of the findings. The articles will appear in the October 4 print issue of JAMA.

"It is estimated that more than 30 million people worldwide take nonsteroidal anti-inflammatory drugs (NSAIDs) daily for treatment of pain and inflammation," according to background information provided in one of the articles. Adverse effects of some conventional NSAIDs include toxic gastrointestinal (GI) effects, as well as adverse renal (kidney) effects. "Overall, an estimated 2.5 million individuals in the United States annually experience adverse renal effects caused by use of NSAIDs," the authors write. "With decreased risk of adverse GI effects, a class of drugs that selectively inhibits COX-2 enzyme was introduced for analgesia (pain relief) and the treatment of arthritis." According to the authors, the adverse renal effects of selective COX-2 inhibition are unclear. Evidence is accumulating on the potential class effect of COX-2 inhibitors on cardiovascular risk. Two COX-2 inhibitors have already been withdrawn from the market: rofecoxib (marketed as Vioxx) and valdecoxib (marketed as Bextra).

Jingjing Zhang, M.D., Ph.D., from Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues evaluated the adverse risks of renal events and arrhythmia (disturbance of the normal heart rhythm) events in patients prescribed COX-2 inhibitors from a systematic review of the medical literature to determine if these negative side-effects involve every drug in this class.

"In this comprehensive meta-analysis of 114 randomized trials of COX-2 inhibitors comprised of 116,094 participants, rofecoxi
'"/>

Contact: Todd Datz
617-432-3952
JAMA and Archives Journals
12-Sep-2006


Page: 1 2 3 4 5

Related medicine news :

1. Studies show antidepressants not linked to birth defects
2. Studies show role of age, gender, race and weight on cancer risk and treatment
3. Studies suggest investigational agent reduces disease activity in MS
4. Studies highlight advances in diagnosis, medical therapy
5. Studies highlight real world use, safety of drug-eluting stents
6. Studies led by Rhode Island Hospital confirm safety and efficacy
7. Studies identify food sources of disease and drug resistance
8. Studies highlight need to monitor heart function in breast cancer patients
9. Studies examine physician disclosure of medical errors
10. Studies indicate medication can be an effective therapy for smoking cessation
11. Studies evaluating health effects of dental amalgam fillings in children confirm safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/13/2018)... ... December 13, 2018 , ... Individuals who are interested ... to win a full-ride scholarship offered by Dr. Kami Hoss of Howard Healthcare Academy. ... The full-ride scholarship would enable a student to become a registered dental assistant for ...
(Date:12/10/2018)... LINDA, Calif. (PRWEB) , ... December 10, 2018 , ... ... assessing all 18 major freight railyards in California and found a link with freight-railyard ... in Preventive Medicine Reports. , This large-scale railyard study is a ...
(Date:12/10/2018)... ... December 10, 2018 , ... ... Emergency Room and Florida Hospital Wesley Chapel recently received the 2018 Press Ganey ... patient experience. The award for both emergency and inpatient services is measured through ...
(Date:12/8/2018)... ... December 07, 2018 , ... “The Better World Campaign ... affairs, U.S. leadership and funding at the United Nations matters. We have seen ... extreme poverty and advancing global health plus meaningful reforms in development, management, and ...
(Date:12/6/2018)... ... December 06, 2018 , ... HMP, a leader ... Symposium (PACS). The meeting will take place May 9–10, 2019, and will be ... in San Antonio, Texas. , PACS is uniquely designed to provide nurses with ...
Breaking Medicine News(10 mins):
(Date:12/10/2018)... IRVING, Texas (PRWEB) , ... December 10, 2018 , ... ... 1, 2019. Witty joined MADD in 2000 after her 16-year-old daughter, Helen Marie, was ... near the family’s home in Miami on a clear June afternoon. , “I landed ...
(Date:12/8/2018)... ... December 07, 2018 , ... American Vision ... in the nation, and Southwestern Eye Center, an affiliate of American Vision Partners, ... the two businesses will improve the quality of care for patients in the ...
(Date:12/8/2018)... ... December 07, 2018 , ... Cardiologist Ernst von Schwarz, MD says that ... other issues or ignored completely by their doctors. “This can be especially dangerous in ... women can educate themselves on symptoms that are unique to women so they may ...
Breaking Medicine Technology:
Cached News: